Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL ‐6 and Insulin in Patients With Polycystic Ovary Syndrome
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70442 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Samaneh Jamshidian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Interleukin-6, Plant Oils, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder that affects 5%–10% of women of reproductive age. Supplements with potential anti‐inflammatory properties, such as Nigella sativa oil, have been proposed as adjunctive therapies that may improve selected metabolic and inflammatory features of PCOS.
Objective
This study investigated the effect of N. sativa oil on serum levels of IL‐6 and insulin in patients with polycystic ovary syndrome.
Method
This study was a randomized, double‐blind, placebo‐controlled clinical trial conducted on 60 PCOS patients. Patients received either N. sativa oil supplementation (1000 mg daily) or placebo for 12 weeks. Intermenstrual interval, menstrual duration, fasting blood glucose, insulin, insulin resistance, and serum IL‐6 levels were measured.
Results
Sixty women with PCOS were randomized equally to the intervention and placebo groups. After baseline adjustment, serum IL‐6 (adjusted mean difference −4.21; 95% CI −6.34 to −2.08; p < 0.001) and fasting blood glucose (adjusted mean difference −8.16 mg/dL; 95% CI −12.73 to −3.58; p < 0.001) were significantly lower in the N. sativa group than in the placebo group. No significant between‐group differences were observed for fasting insulin, HOMA‐IR, QUICKI, luteinizing hormone, or total testosterone. The intermenstrual interval was significantly shorter in the intervention group, whereas menstrual duration and other clinical manifestations showed no significant between‐group differences.
Conclusion
Twelve weeks of N. sativa oil supplementation were associated with significant improvements in inflammatory status and fasting blood glucose compared with placebo after baseline adjustment. However, no significant between‐group effects were observed for insulin resistance indices or hormonal outcomes. These findings support the potential adjunctive role of N. sativa oil in PCOS while highlighting the need for larger adequately powered clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
ORCID-Profile: Samaneh Jamshidian, Faranak Jalilvand
Zitieren
APA
Jamshidian, S., & Jalilvand, F. (2026). Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL ‐6 and Insulin in Patients With Polycystic Ovary Syndrome. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70442
Vancouver
Jamshidian S, Jalilvand F. Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL ‐6 and Insulin in Patients With Polycystic Ovary Syndrome. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70442
BibTeX
@article{Jamshidian2026,
author = {Jamshidian, Samaneh and Jalilvand, Faranak},
title = {Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL ‐6 and Insulin in Patients With Polycystic Ovary Syndrome},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70442}
}
EUVIMED